749
Views
9
CrossRef citations to date
0
Altmetric
Review

Using DPP-4 inhibitors to modulate beta cell function in type 1 diabetes and in the treatment of diabetic kidney disease

Pages 377-388 | Received 17 Oct 2018, Accepted 05 Mar 2019, Published online: 19 Mar 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Piyush Verma, Lajpreet Kaur, Priyanka Aswal, Anju Singh, Himanshu Ojha, Afreen Jahan Rahman, Rahul Singhal, Anjani K. Tiwari & Mallika Pathak. (2023) Luminescence studies of binding affinity of vildagliptin with bovine serum albumin. Journal of Biomolecular Structure and Dynamics 41:7, pages 3002-3013.
Read now

Articles from other publishers (8)

Haitham G. Zakaraia, Heba F. Salem, Mostafa A. A. Mostafa, Ahmed M. Ali & Hoda M. Rabea. (2023) Empagliflozin versus Sitagliptin as add-on dual therapy in Egyptian patients with type 2 diabetes inadequately controlled with Metformin: a 12-week randomized, open-label, parallel-group trial. Beni-Suef University Journal of Basic and Applied Sciences 12:1.
Crossref
Pin-Jian Xiao, Jia-Cheng Zeng, Ping Lin, Dao-Bang Tang, En Yuan, Yong-Gang Tu, Qing-Feng Zhang, Ji-Guang Chen, Da-Yong Peng & Zhong-Ping Yin. (2022) Chalcone-1-Deoxynojirimycin Heterozygote Reduced the Blood Glucose Concentration and Alleviated the Adverse Symptoms and Intestinal Flora Disorder of Diabetes Mellitus Rats. Molecules 27:21, pages 7583.
Crossref
Yuanyuan Zhang, Ying Fu, Yuxian Yang, Jing Ke & Dong Zhao. (2022) Assessment of serum dipeptidyl peptidase-IV levels in autoimmune thyroid disease. Journal of International Medical Research 50:7, pages 030006052211120.
Crossref
Madhu Pujar, Basavaraj Vastrad, Satish Kavatagimath, Chanabasayya Vastrad & Shivakumar Kotturshetti. (2022) Identification of candidate biomarkers and pathways associated with type 1 diabetes mellitus using bioinformatics analysis. Scientific Reports 12:1.
Crossref
Junmin Wang, Hongjiao Xiang, Yifei Lu, Tao Wu & Guang Ji. (2021) New progress in drugs treatment of diabetic kidney disease. Biomedicine & Pharmacotherapy 141, pages 111918.
Crossref
Eiji Kutoh, Alexandra N. Kuto, Askuka Wada, Jyunka Hayashi & Rumi Kurihara. (2020) Sitagliptin as an Initial Therapy and Differential Regulations of Metabolic Parameters Depending on its Glycemic Response in Subjects with Type 2 Diabetes. Drug Research 71:03, pages 157-165.
Crossref
Ruichen Zhao, Zhiguo Lu, Jun Yang, Liqun Zhang, Yan Li & Xin Zhang. (2020) Drug Delivery System in the Treatment of Diabetes Mellitus. Frontiers in Bioengineering and Biotechnology 8.
Crossref
Sandra Rayego-Mateos, José Luis Morgado-Pascual, Lucas Opazo-Ríos, Melania Guerrero-Hue, Cristina García-Caballero, Cristina Vázquez-Carballo, Sebastián Mas, Ana Belén Sanz, Carmen Herencia, Sergio Mezzano, Carmen Gómez-Guerrero, Juan Antonio Moreno & Jesús Egido. (2020) Pathogenic Pathways and Therapeutic Approaches Targeting Inflammation in Diabetic Nephropathy. International Journal of Molecular Sciences 21:11, pages 3798.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.